Small Molecule Inhibitors of RNA-Binding Protein Musashi for Cancer Treatment
University of Kansas, KS, United States
The invention relates to small molecules modulating functions of the RNA-binding protein Musashi for cancer treatment.
Primary Application Area: Pharmaceuticals & Personal Care
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
FIGURES OF MERIT
Value Proposition: Unique chemical compounds and thus strong patent strength.
Organization Type: Academic/Gov Lab
Showcase Booth #: 13M
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date:
Primary Sources of Funding: Federal Grant, University
Looking for: Both Funding and Development Partners